InsidersTradesSigma
Indegene Stock: price and insider trades · India · SEBI (PIT + SAST)
Track the Indegene share price and the full management transaction log of the company, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €126.7bn. The latest transaction was filed on 12 June 2026 (Disposal). Among the most active insiders: Shouvanik Chatterjee. The full history is free.
1
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€162,616
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Indegene Buy (bullish), based on 7 analysts. Average price target: ₹592.43.
10Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,460 of 25,443 companies
64.1
score / 100
Value49
Quality79
FCF yld5.1%
Earn yld3.4%
EV/EBITDA18.0x
ROE14%
Gross mgn·
Net mgn11%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 June 2026
Declarations1 total
34,000 shares@ ₹526.60100.0% of flowEquity SharesMarket SaleSEBI:e2ea38fb40476aec22059df1c4644a9daa0d7f53
1 of 1 declaration
About Indegene
Indegene is a company specializing in digital health solutions and marketing services for pharmaceutical and biopharmaceutical companies. It offers services ranging from strategy to execution, integrating advanced technologies.